A pediatric gateway initiative for glomerular disease: introducing PIONEER-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A pediatric gateway initiative for glomerular disease: introducing PIONEER

Published:2021-03 Issue:3 Volume:99 Page:515-518
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Gipson Debbie S.,Tarnoff Joshua,Lee Lauren,Vivarelli Marina,Levtchenko Elena,Oh Jun,Smoyer William E.,Desmond Hailey,Attalla Samara,Trachtman Howard

Funder

U.S. Food and Drug Administration

Publisher

Elsevier BV

Subject

Nephrology

Reference6 articles.

1. Analysis of the global burden of disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016;Xie;Kidney Int,2018

2. Systems biology approaches to identify disease mechanisms and facilitate targeted therapy in the management of glomerular disease;Hamidi;Curr Opin Nephrol Hypertens,2018

3. An outcomes-based definition of proteinuria remission in focal segmental glomerulosclerosis;Troost;Clin J Am Soc Nephrol,2018

4. Cardiovascular disease in children and adolescents with chronic kidney disease;Weaver;Semin Nephrol,2018

5. Ethical drug development for rare childhood diseases: when there are limited but promising data in adults, how to choose between safety or efficacy studies?;Johnson;Am J Bioeth,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridging the 13-Year Evidence Gap: A Time for Age-Inclusive Research;Journal of the American Society of Nephrology;2024-01-15

2. Pioglitazone enhances proteinuria reduction in complicated pediatric nephrotic syndrome;Pediatric Nephrology;2022-08-15

3. Recent advances in immunotherapies for lupus nephritis;Pediatric Nephrology;2022-07-01

4. The Evidence for Sparsentan-Mediated Inhibition of INa and IK(erg): Possibly Unlinked to Its Antagonism of Angiotensin II or Endothelin Type a Receptor;Biomedicines;2021-12-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3